Видео ютуба по тегу Monumental-1

MonumenTAL-1: talquetamab in R/R multiple myeloma
MonumenTAL-1: talquetamab in R/R multiple myeloma
MonumenTAL-1: talquetamab for multiple myeloma
MonumenTAL-1: talquetamab for multiple myeloma
Results from MonumenTAL-1: First-in-Human Study of Talquetamab in Pts with RR Multiple Myeloma
Results from MonumenTAL-1: First-in-Human Study of Talquetamab in Pts with RR Multiple Myeloma
Talquetamab in Pts with Relapsed/Refractory Multiple Myeloma: Phase 1/2 Results from MonumenTAL-1
Talquetamab in Pts with Relapsed/Refractory Multiple Myeloma: Phase 1/2 Results from MonumenTAL-1
MonumenTAL-1: updated data on talquetamab in R/R myeloma
MonumenTAL-1: updated data on talquetamab in R/R myeloma
EHA 2023 | MonumenTAL1 clinical trial
EHA 2023 | MonumenTAL1 clinical trial
MonumenTAL-1 update: talquetamab in R/R multiple myeloma
MonumenTAL-1 update: talquetamab in R/R multiple myeloma
MonumenTAL-1: incidence of severe infections & parameters of humoral immunity with talquetamab
MonumenTAL-1: incidence of severe infections & parameters of humoral immunity with talquetamab
Updates from the MonumenTAL-1 trial
Updates from the MonumenTAL-1 trial
Montagem Dilatricação Monumental 1
Montagem Dilatricação Monumental 1
Updates on Efficacy/Safety Results from MonumenTAL-1 (Talquetamab) in RRMM patients
Updates on Efficacy/Safety Results from MonumenTAL-1 (Talquetamab) in RRMM patients
Monumental 1
Monumental 1
Ajai Chari, MD, Discusses the MonumenTAL-1 Study
Ajai Chari, MD, Discusses the MonumenTAL-1 Study
Compacto de Giat 2 Monumental 1 (Torneo Apertura 2017)
Compacto de Giat 2 Monumental 1 (Torneo Apertura 2017)
ASH 2023 | Relapsed and refractory myeloma: Phase 1/2 MonumenTAL 1 Study
ASH 2023 | Relapsed and refractory myeloma: Phase 1/2 MonumenTAL 1 Study